Gene · 9869
Papers2,616
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,616
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Self-amplifying loop of NF-κB and periostin initiated by PIEZO1 accelerates mechano-induced senescence of nucleus pulposus cells and intervertebral disc degeneration. | Mol Ther | 2022 | 35619555 | PubTator, text mining | PubMed |
| Retraction Notice to: Hypoxic tumor-derived exosomal circular RNA SETDB1 promotes invasive growth and EMT via the miR-7/Sp1 axis in lung adenocarcinoma. | Mol Ther Nucleic Acids | 2022 | 35614997 | PubTator, text mining | PubMed |
| Disrupting Mechanisms that Regulate Genomic Repeat Elements to Combat Cancer and Drug Resistance. | Front Cell Dev Biol | 2022 | 35602594 | PubTator, text mining | PubMed |
| The Effect of miRNA Gene Regulation on HIV Disease. | Front Genet | 2022 | 35601502 | PubTator, text mining | PubMed |
| Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells. | Front Oncol | 2022 | 35600367 | PubTator, text mining | PubMed |
| PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition. | Cell Death Dis | 2022 | 35597793 | PubTator, text mining | PubMed |
| H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer. | Proc Natl Acad Sci U S A | 2022 | 35584120 | PubTator, text mining | PubMed |
| PRMT inhibition induces a viral mimicry response in triple-negative breast cancer. | Nat Chem Biol | 2022 | 35578032 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. | Nat Rev Mol Cell Biol | 2022 | 35562425 | PubTator, text mining | PubMed |
| Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis. | Oncogene | 2022 | 35546351 | PubTator, text mining | PubMed |
| Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter. | Front Oncol | 2022 | 35515106 | PubTator, text mining | PubMed |
| Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer. | Front Immunol | 2022 | 35514980 | PubTator, text mining | PubMed |
| Identification and characterization of a novel enhancer in the HTLV-1 proviral genome. | Nat Commun | 2022 | 35504920 | PubTator, text mining | PubMed |
| Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway. | J Immunol Res | 2022 | 35497876 | PubTator, text mining | PubMed |
| Corrigendum: The Role of Histone Lysine Methylation in the Response of Mammalian Cells to Ionizing Radiation. | Front Genet | 2022 | 35495134 | PubTator, text mining | PubMed |
| SETDB1 fuels the lung cancer phenotype by modulating epigenome, 3D genome organization and chromatin mechanical properties. | Nucleic Acids Res | 2022 | 35474385 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2. | Nat Commun | 2022 | 35469023 | PubTator, text mining | PubMed |
| PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA. | Cell Death Dis | 2022 | 35468873 | PubTator, text mining | PubMed |
| Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care. | Front Cell Dev Biol | 2022 | 35465311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9869/papers?page=35